Skip to content

Nischarin (NISCH)

Homo sapiens — UniProt Q9Y2I1

Gene: NISCHHomo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Nischarin (NISCH) is a protein from Homo sapiens identified by UniProt accession Q9Y2I1, 1504 residues long. MolForge cross-references it against 12 known binders and 162 disease associations.

  • UniProt accession: Q9Y2I1; gene symbol NISCH.
  • Organism: Homo sapiens.
  • Length: 1504 amino acids.
  • Approved drugs acting on it (DrugCentral): Moxonidine.
  • Top disease associations (Open Targets): hypertension, Parkinson disease and neurodegenerative disease.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameNischarin
UniProt accessionQ9Y2I1
GeneNISCH
OrganismHomo sapiens
Length1504 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). Approved drug exists

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Approved drugs acting on this target (1)

Approved drugs whose DrugCentral mechanism of action is this protein, most potent first.

Disease associations (162)

Diseases linked to this target (Open Targets).

  • hypertension · score 0.49
  • Parkinson disease · score 0.43
  • neurodegenerative disease · score 0.43
  • lysosomal storage disease · score 0.43
  • multiple sclerosis · score 0.43
  • Alzheimer disease · score 0.43
  • schizophrenia · score 0.37
  • nervous system disease · score 0.37
  • polycystic ovary syndrome · score 0.37
  • diabetic nephropathy · score 0.37

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9Y2I1-F1alphafoldPREDICTED68.81—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9Y2I1.

Amino-acid sequence (1504 residues)

MATARTFGPE REAEPAKEAR VVGSELVDTY TVYIIQVTDG SHEWTVKHRY SDFHDLHEKL VAERKIDKNL LPPKKIIGKN SRSLVEKREK DLEVYLQKLL AAFPGVTPRV LAHFLHFHFY EINGITAALA EELFEKGEQL LGAGEVFAIG PLQLYAVTEQ LQQGKPTCAS GDAKTDLGHI LDFTCRLKYL KVSGTEGPFG TSNIQEQLLP FDLSIFKSLH QVEISHCDAK HIRGLVASKP TLATLSVRFS ATSMKEVLVP EASEFDEWEP EGTTLEGPVT AVIPTWQALT TLDLSHNSVS EIDESVKLIP KIEFLDLSHN GLLVVDNLQH LYNLVHLDLS YNKLSSLEGL HTKLGNIKTL NLAGNLLESL SGLHKLYSLV NLDLRDNRIE QMEEVRSIGS LPCLEHVSLL NNPLSIIPDY RTKVLAQFGE RASEVCLDDT VTTEKELDTV EVLKAIQKAK EVKSKLSNPE KKGGEDSRLS AAPCIRPSSS PPTVAPASAS LPQPILSNQG IMFVQEEALA SSLSSTDSLT PEHQPIAQGC SDSLESIPAG QAASDDLRDV PGAVGGASPE HAEPEVQVVP GSGQIIFLPF TCIGYTATNQ DFIQRLSTLI RQAIERQLPA WIEAANQREE GQGEQGEEED EEEEEEEDVA ENRYFEMGPP DVEEEEGGGQ GEEEEEEEED EEAEEERLAL EWALGADEDF LLEHIRILKV LWCFLIHVQG SIRQFAACLV LTDFGIAVFE IPHQESRGSS QHILSSLRFV FCFPHGDLTE FGFLMPELCL VLKVRHSENT LFIISDAANL HEFHADLRSC FAPQHMAMLC SPILYGSHTS LQEFLRQLLT FYKVAGGCQE RSQGCFPVYL VYSDKRMVQT AAGDYSGNIE WASCTLCSAV RRSCCAPSEA VKSAAIPYWL LLTPQHLNVI KADFNPMPNR GTHNCRNRNS FKLSRVPLST VLLDPTRSCT QPRGAFADGH VLELLVGYRF VTAIFVLPHE KFHFLRVYNQ LRASLQDLKT VVIAKTPGTG GSPQGSFADG QPAERRASND QRPQEVPAEA LAPAPAEVPA PAPAAASASG PAKTPAPAEA STSALVPEET PVEAPAPPPA EAPAQYPSEH LIQATSEENQ IPSHLPACPS LRHVASLRGS AIIELFHSSI AEVENEELRH LMWSSVVFYQ TPGLEVTACV LLSTKAVYFV LHDGLRRYFS EPLQDFWHQK NTDYNNSPFH ISQCFVLKLS DLQSVNVGLF DQHFRLTGST PMQVVTCLTR DSYLTHCFLQ HLMVVLSSLE RTPSPEPVDK DFYSEFGNKT TGKMENYELI HSSRVKFTYP SEEEIGDLTF TVAQKMAEPE KAPALSILLY VQAFQVGMPP PGCCRGPLRP KTLLLTSSEI FLLDEDCVHY PLPEFAKEPP QRDRYRLDDG RRVRDLDRVL MGYQTYPQAL TLVFDDVQGH DLMGSVTLDH FGEVPGGPAR ASQGREVQWQ VFVPSAESRE KLISLLARQW EALCGRELPV ELTG

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which approved drugs target NISCH?

DrugCentral lists 1 approved drug whose mechanism of action is NISCH: Moxonidine.

Which diseases are associated with NISCH?

The strongest Open Targets associations for NISCH are hypertension, Parkinson disease, neurodegenerative disease, lysosomal storage disease and multiple sclerosis.

How long is the NISCH protein?

The Homo sapiens NISCH protein (UniProt Q9Y2I1) is 1504 amino acids long.

Browse: Targets: N · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Nischarin with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9Y2I1
GeneNISCH
OrganismHomo sapiens
Length1504
Binders12
Diseases162
View on UniProt